Joseph Bincy, Zachariah Sunitha K, Abraham Saramma P
Department of Anaesthesia, MOSC Medical College, Kolenchery, Kerala, India.
J Anaesthesiol Clin Pharmacol. 2020 Jul-Sep;36(3):377-380. doi: 10.4103/joacp.JOACP_313_18. Epub 2020 Sep 14.
Transversus abdominis plane (TAP) block has been effectively used for anterior abdominal wall analgesia. The aim of the study was to compare the duration of analgesia produced by two drugs fentanyl and dexmedetomidine as adjuvants to ropivacaine in TAP block under ultrasound-guidance after lower segment cesarean section in a randomized controlled trial.
Sixty-four women of American Society of Anaesthesiologists (ASA) physical status II coming for cesarean sections were randomized to receive TAP blocks on each side of the abdomen using the local anesthetic drug 20 ml of 0.5% ropivacaine with either fentanyl 25 mcg or dexmedetomidine 25 mcg. A ten point numerical pain score was done at baseline, at 1 h and then at intervals of 4 h postoperatively. The hemodynamic parameters such as heart rate, blood pressure, and pulse oximetry were also monitored as above. The time to first analgesia demand from the time of the block and the total analgesic consumption were recorded. The statistical analysis was done by Mann-Whitney U test and the analgesics consumption by using Chi-square test with R software.
Our primary end-point was to assess the duration of analgesia produced by fentanyl added to ropivacaine for ultrasound-guided TAP block, which were 125 min with Q1-Q3 as 110-180 and dexmedetomidine 130 min with Q1-Q3 as 105-161 ( value = 0.47). The amount of analgesics used in the postoperative period in both the groups were analyzed using the Chi-square test not found to have any significant difference between both the groups (-value = 0.512).
Fentanyl and dexmedetomidine as adjuvants to ropivacaine in ultrasound-guided TAP block were equally effective in both prolongation of analgesia and reducing the total consumption of analgesics.
腹横肌平面(TAP)阻滞已有效地用于腹壁前部镇痛。本研究的目的是在一项随机对照试验中,比较剖宫产术后在超声引导下TAP阻滞中,芬太尼和右美托咪定这两种药物作为罗哌卡因辅助剂所产生的镇痛持续时间。
64例美国麻醉医师协会(ASA)身体状况为II级的剖宫产女性被随机分为两组,在腹部两侧接受TAP阻滞,使用20 ml 0.5%罗哌卡因局部麻醉药,其中一组加入25 mcg芬太尼,另一组加入25 mcg右美托咪定。在基线、术后1小时以及术后每隔4小时进行10分数字疼痛评分。同时如上监测心率、血压和脉搏血氧饱和度等血流动力学参数。记录从阻滞时起至首次需要镇痛的时间以及总镇痛药物消耗量。采用曼-惠特尼U检验进行统计分析,使用R软件通过卡方检验分析镇痛药物消耗量。
我们的主要终点是评估在超声引导下TAP阻滞中,添加到罗哌卡因中的芬太尼所产生的镇痛持续时间,为125分钟,四分位数间距(Q1 - Q3)为110 - 180分钟;右美托咪定的镇痛持续时间为130分钟,Q1 - Q3为105 - 161分钟(P值 = 0.47)。使用卡方检验分析两组术后镇痛药物使用量,发现两组之间无显著差异(P值 = 0.512)。
在超声引导下TAP阻滞中,芬太尼和右美托咪定作为罗哌卡因的辅助剂,在延长镇痛时间和减少镇痛药物总消耗量方面同样有效。